Digital microfluidics (DMF) is an emerging liquid-handling technology based on arrays of
microelectrodes for the precise manipulation of discrete droplets. DMF offers the benefits of …

Droplet-based microfluidic devices hold immense potential in becoming inexpensive
alternatives to existing screening platforms across life science applications, such as enzyme …

Bacteria are widely studied in various research areas, including synthetic biology,
sequencing and diagnostic testing. Protocols involving bacteria are often multistep …

We present the first digital microfluidic (DMF) antimicrobial susceptibility test (AST) using an
optical oxygen sensor film for in-situ and real-time continuous measurement of extracellular …

Droplet microfluidics is a technique that has the ability to compartmentalize reactions in sub
nano-(or pico-) liter volumes that can potentially enable millions of distinct biological assays …

Digital microfluidics (DMF) has the signatures of an ideal liquid handling platform–as shown
through almost two decades of automated biological and chemical assays. However, in the …

Existing microfluidic technologies for blood tests have several limitations, including
difficulties in integrating the sample preparation steps, such as blood dilution, and precise …

Gene-editing techniques such as RNA-guided endonuclease systems are becoming
increasingly popular for phenotypic screening. Such screens are normally conducted in …

The future of the life sciences is linked to automation and microfluidics. As robots start
working side by side with scientists, robotic automation of microfluidics in general, and …

Overweight and obesity promote diabetes and heart disease onset. Triglycerides are key
biomarkers for cardiovascular disease, strokes, and other health issues. Scientists have …